Article Details

Merck, Moderna Launch Phase III Trial of V940 in Combination with Keytruda for Resectable ...

Retrieved on: 2024-10-28 17:41:37

Tags for this article:

Click the tags to see associated articles and topics

Merck, Moderna Launch Phase III Trial of V940 in Combination with Keytruda for Resectable .... View article details on hiswai:

Excerpt

Collaboration seeks to advance the treatment of non-small cell lung cancer by combining Keytruda with Moderna's novel neoantigen therapy, ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up